Zdrowie i gospodarka · 27/07/2018

FDA Announces Generic Drug User Fee Rates for Fiscal Year 2019

The Food and Drug Administration (FDA) is setting fees for abbreviated new drug applications, drug master files, and other generic drug-related services for fiscal year 2019, as mandated by the Generic Drug User Fee Amendments of 2017.